vs

Side-by-side financial comparison of Lamb Weston (LW) and ResMed (RMD). Click either name above to swap in a different company.

Lamb Weston is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.1× ResMed). ResMed runs the higher net margin — 27.6% vs 3.5%, a 24.1% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 2.9%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs -1.5%).

Lamb Weston Holdings, Inc. is an American food processing company that is one of the world's largest producers and processors of frozen french fries, waffle fries, and other frozen potato products. It is headquartered in Eagle, Idaho, a suburb of Boise.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

LW vs RMD — Head-to-Head

Bigger by revenue
LW
LW
1.1× larger
LW
$1.6B
$1.4B
RMD
Growing faster (revenue YoY)
RMD
RMD
+8.1% gap
RMD
11.0%
2.9%
LW
Higher net margin
RMD
RMD
24.1% more per $
RMD
27.6%
3.5%
LW
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
-1.5%
LW

Income Statement — Q3 FY2026 vs Q4 FY2026

Metric
LW
LW
RMD
RMD
Revenue
$1.6B
$1.4B
Net Profit
$54.0M
$392.6M
Gross Margin
21.2%
61.8%
Operating Margin
8.1%
34.6%
Net Margin
3.5%
27.6%
Revenue YoY
2.9%
11.0%
Net Profit YoY
-63.0%
13.9%
EPS (diluted)
$0.39
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LW
LW
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.6B
Q4 25
$1.6B
$1.4B
Q3 25
$1.7B
$1.3B
Q2 25
$1.7B
$1.3B
Q1 25
$1.5B
$1.3B
Q4 24
$1.6B
$1.3B
Q3 24
$1.7B
$1.2B
Net Profit
LW
LW
RMD
RMD
Q2 26
$392.6M
Q1 26
$54.0M
Q4 25
$62.1M
$392.6M
Q3 25
$64.3M
$348.5M
Q2 25
$119.9M
$379.7M
Q1 25
$146.0M
$365.0M
Q4 24
$-36.1M
$344.6M
Q3 24
$127.4M
$311.4M
Gross Margin
LW
LW
RMD
RMD
Q2 26
61.8%
Q1 26
21.2%
Q4 25
20.0%
61.8%
Q3 25
20.6%
61.5%
Q2 25
20.4%
60.8%
Q1 25
27.8%
59.3%
Q4 24
17.4%
58.6%
Q3 24
21.5%
58.6%
Operating Margin
LW
LW
RMD
RMD
Q2 26
34.6%
Q1 26
8.1%
Q4 25
8.6%
34.6%
Q3 25
9.4%
33.4%
Q2 25
11.1%
33.7%
Q1 25
16.4%
33.0%
Q4 24
1.2%
32.5%
Q3 24
12.8%
31.6%
Net Margin
LW
LW
RMD
RMD
Q2 26
27.6%
Q1 26
3.5%
Q4 25
3.8%
27.6%
Q3 25
3.9%
26.1%
Q2 25
7.2%
28.2%
Q1 25
9.6%
28.3%
Q4 24
-2.3%
26.9%
Q3 24
7.7%
25.4%
EPS (diluted)
LW
LW
RMD
RMD
Q2 26
$2.68
Q1 26
$0.39
Q4 25
$0.44
$2.68
Q3 25
$0.46
$2.37
Q2 25
$0.84
$2.58
Q1 25
$1.03
$2.48
Q4 24
$-0.25
$2.34
Q3 24
$0.88
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LW
LW
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$57.5M
$1.4B
Total DebtLower is stronger
$3.6B
$663.8M
Stockholders' EquityBook value
$1.8B
$6.3B
Total Assets
$7.4B
$8.5B
Debt / EquityLower = less leverage
1.99×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LW
LW
RMD
RMD
Q2 26
$1.4B
Q1 26
$57.5M
Q4 25
$82.7M
$1.4B
Q3 25
$98.6M
$1.4B
Q2 25
$70.7M
$1.2B
Q1 25
$67.5M
$932.7M
Q4 24
$79.0M
$521.9M
Q3 24
$120.8M
$426.4M
Total Debt
LW
LW
RMD
RMD
Q2 26
$663.8M
Q1 26
$3.6B
Q4 25
$3.6B
$403.9M
Q3 25
$3.7B
$408.7M
Q2 25
$3.7B
$658.4M
Q1 25
$3.7B
$663.1M
Q4 24
$3.7B
$662.9M
Q3 24
$3.4B
$667.6M
Stockholders' Equity
LW
LW
RMD
RMD
Q2 26
$6.3B
Q1 26
$1.8B
Q4 25
$1.8B
$6.3B
Q3 25
$1.8B
$6.1B
Q2 25
$1.7B
$6.0B
Q1 25
$1.6B
$5.5B
Q4 24
$1.6B
$5.3B
Q3 24
$1.8B
$5.2B
Total Assets
LW
LW
RMD
RMD
Q2 26
$8.5B
Q1 26
$7.4B
Q4 25
$7.3B
$8.5B
Q3 25
$7.2B
$8.3B
Q2 25
$7.4B
$8.2B
Q1 25
$7.4B
$7.6B
Q4 24
$7.5B
$7.1B
Q3 24
$7.5B
$7.2B
Debt / Equity
LW
LW
RMD
RMD
Q2 26
0.11×
Q1 26
1.99×
Q4 25
2.08×
0.06×
Q3 25
2.05×
0.07×
Q2 25
2.12×
0.11×
Q1 25
2.25×
0.12×
Q4 24
2.26×
0.13×
Q3 24
1.87×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LW
LW
RMD
RMD
Operating Cash FlowLast quarter
$65.2M
Free Cash FlowOCF − Capex
$-36.3M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
1.21×
TTM Free Cash FlowTrailing 4 quarters
$569.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LW
LW
RMD
RMD
Q2 26
Q1 26
$65.2M
Q4 25
$178.4M
$339.7M
Q3 25
$352.0M
$457.3M
Q2 25
$868.3M
$538.8M
Q1 25
$56.0M
$578.7M
Q4 24
$99.1M
$308.6M
Q3 24
$330.2M
$325.5M
Free Cash Flow
LW
LW
RMD
RMD
Q2 26
Q1 26
$-36.3M
Q4 25
$101.0M
$311.2M
Q3 25
$274.4M
$414.4M
Q2 25
$230.1M
$508.2M
Q1 25
$-19.8M
$557.9M
Q4 24
$-49.6M
$288.0M
Q3 24
$4.3M
$307.7M
FCF Margin
LW
LW
RMD
RMD
Q2 26
Q1 26
-2.3%
Q4 25
6.2%
21.9%
Q3 25
16.5%
31.0%
Q2 25
13.7%
37.7%
Q1 25
-1.3%
43.2%
Q4 24
-3.1%
22.5%
Q3 24
0.3%
25.1%
Capex Intensity
LW
LW
RMD
RMD
Q2 26
Q1 26
6.5%
Q4 25
4.8%
2.0%
Q3 25
4.7%
3.2%
Q2 25
38.1%
2.3%
Q1 25
5.0%
1.6%
Q4 24
9.3%
1.6%
Q3 24
19.7%
1.5%
Cash Conversion
LW
LW
RMD
RMD
Q2 26
Q1 26
1.21×
Q4 25
2.87×
0.87×
Q3 25
5.47×
1.31×
Q2 25
7.24×
1.42×
Q1 25
0.38×
1.59×
Q4 24
0.90×
Q3 24
2.59×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LW
LW

Segments North America$1.0B66%
Segments International$529.8M34%

RMD
RMD

Segment breakdown not available.

Related Comparisons